Pan-methylarginine antibody generation using PEG linked GAR motifs as antigens.

[1]  Timothy W. Sikorski,et al.  Identification of hnRNP-A1 as a pharmacodynamic biomarker of type I PRMT inhibition in blood and tumor tissues , 2020, Scientific Reports.

[2]  Jason D. Ray,et al.  Generation and Characterization of Anti-Glucosepane Antibodies Enabling Direct Detection of Glucosepane in Retinal Tissue. , 2020, ACS chemical biology.

[3]  Bas J. Wouters,et al.  Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation. , 2019, Cancer cell.

[4]  U. Ghoshdastider,et al.  Proteomics profiling of arginine methylation defines PRMT5 substrate specificity , 2019, Science Signaling.

[5]  K. Berkner,et al.  VKOR paralog VKORC1L1 supports vitamin K-dependent protein carboxylation in vivo. , 2018, JCI insight.

[6]  K. Saikatendu,et al.  TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma , 2018, Oncotarget.

[7]  N. Karnani,et al.  An Alternative Strategy for Pan-acetyl-lysine Antibody Generation , 2016, PloS one.

[8]  Kyle V. Butler,et al.  A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases. , 2016, ACS chemical biology.

[9]  B. Blencowe,et al.  SMN and symmetric arginine dimethylation of RNA polymerase II C-terminal domain control termination , 2015, Nature.

[10]  D. Spiegel,et al.  Generation and characterization of antibodies against arginine-derived advanced glycation endproducts. , 2015, Bioorganic & medicinal chemistry letters.

[11]  Robert A Copeland,et al.  A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models. , 2015, Nature chemical biology.

[12]  Dirk Walther,et al.  The Roles of Post-translational Modifications in the Context of Protein Interaction Networks , 2015, PLoS Comput. Biol..

[13]  Ailan Guo,et al.  PRMT9 is a Type II methyltransferase that methylates the splicing factor SAP145 , 2015, Nature Communications.

[14]  Ailan Guo,et al.  Immunoaffinity Enrichment and Mass Spectrometry Analysis of Protein Methylation , 2013, Molecular & Cellular Proteomics.

[15]  I. Fearnley,et al.  NDUFAF7 Methylates Arginine 85 in the NDUFS2 Subunit of Human Complex I* , 2013, The Journal of Biological Chemistry.

[16]  S. Richard,et al.  Defining the RGG/RG motif. , 2013, Molecular cell.

[17]  S. Richard,et al.  Loss of the major Type I arginine methyltransferase PRMT1 causes substrate scavenging by other PRMTs , 2013, Scientific Reports.

[18]  Peer Bork,et al.  Deciphering a global network of functionally associated post-translational modifications , 2012, Molecular systems biology.

[19]  D. Reinberg,et al.  Crystal Structure of TDRD3 and Methyl-Arginine Binding Characterization of TDRD3, SMN and SPF30 , 2012, PloS one.

[20]  Troy E. Sandberg,et al.  Human Protein Arginine Methyltransferase 7 (PRMT7) Is a Type III Enzyme Forming ω-NG-Monomethylated Arginine Residues* , 2012, The Journal of Biological Chemistry.

[21]  C. Lorson,et al.  SMN in spinal muscular atrophy and snRNP biogenesis , 2011, Wiley interdisciplinary reviews. RNA.

[22]  S. Clarke,et al.  Uncovering the Human Methyltransferasome* , 2010, Molecular & Cellular Proteomics.

[23]  S. Clarke,et al.  Protein arginine methylation in mammals: who, what, and why. , 2009, Molecular cell.

[24]  François-Michel Boisvert,et al.  A Proteomic Analysis of Arginine-methylated Protein Complexes* , 2003, Molecular & Cellular Proteomics.

[25]  P. Hornbeck,et al.  Phosphoprotein Analysis Using Antibodies Broadly Reactive against Phosphorylated Motifs* , 2002, The Journal of Biological Chemistry.

[26]  R. Lührmann,et al.  Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B' and the Sm-like protein LSm4, and their interaction with the SMN protein. , 2001, RNA.

[27]  Steven Clarke,et al.  PRMT5 (Janus Kinase-binding Protein 1) Catalyzes the Formation of Symmetric Dimethylarginine Residues in Proteins* , 2001, The Journal of Biological Chemistry.

[28]  G. Dreyfuss,et al.  SMN, the product of the spinal muscular atrophy gene, binds preferentially to dimethylarginine-containing protein targets. , 2001, Molecular cell.

[29]  G. Stark,et al.  Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAK1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  B. Turner,et al.  The inactive X chromosome in female mammals is distinguished by a lack of histone H4 acetylation, a cytogenetic marker for gene expression , 1993, Cell.

[31]  G. Piperno,et al.  Identification of an acetylation site of Chlamydomonas alpha-tubulin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. White,et al.  Preparation and use of anti-phosphotyrosine antibodies to study structure and function of insulin receptor. , 1991, Methods in enzymology.